Access to Trial Meds Needs Market Incentive, Conservatives Say

July 24, 2019

Lawmakers and conservative advocates who fought to make it easier for Americans to use experimental medicines are floating a new twist: permitting drugmakers to sell unapproved drugs at a profit.

Related Stories